IKS Health IPO 2024: Key Dates, Price Band, and Investment Details

Inventurus Knowledge Solutions Limited (IKS Health), a leading healthcare technology company, is all set to launch its ₹2,497.9 million Initial Public Offering (IPO) from 12 December to 16 December 2024. With a strong foothold in healthcare administration and technology, IKS Health offers a unique investment opportunity for those looking to benefit from the evolving healthcare landscape.

Here are the 10 key things you should know before investing in the Inventurus Knowledge Solutions Limited IPO:

What makes Inventurus Knowledge Solutions a good opportunity?

Inventurus Knowledge Solutions Limited provides a comprehensive platform to healthcare enterprises, helping them reduce the administrative burden on healthcare providers. It offers end-to-end solutions like virtual medical scribing, medical documentation management, and clinical support.

The company serves over 778 healthcare organisations globally, including renowned clients like Mass General Brigham Inc. and Texas Health Care PLLC. With a robust revenue CAGR of 54.29% (FY22-FY24), IKS Health is well-positioned to capitalise on the growing demand for healthcare technology services.

What are the IPO dates, price band, and issue size?

Here are the key details of the IPO:

IPO dates: December 12th–16th, 2024

Listing date: December 19th, 2024

Price band: ₹1,265–₹1,329 per share

Total issue size: ₹2,497.9 Cr

Face value: ₹1 per share

Listing Exchange: BSE, NSE

Lot Size: 11 Shares

Promoters: Sachin Gupta, Rekha Jhunjhunwala, Aryaman Jhunjhunwala Discretionary Trust, Aryavir Jhunjhunwala Discretionary Trust, and Nishtha Jhunjhunwala Discretionary Trust

What is the minimum investment for the IPO?

The minimum investment required to apply for the Inventurus Knowledge Solutions IPO is ₹13,915, based on the lot size of 11 shares at the lower price band of ₹1,265 per share. However, to increase your chances of allotment, we recommend applying at the upper price band, which would require ₹14,619 (11 shares at ₹1,329 per share).

What does the company do?

Founded in 2006, Inventurus Knowledge Solutions Limited specialises in easing healthcare administrative tasks, enabling faster care delivery for patients.

Services: Includes outpatient and inpatient care solutions, clinical support, virtual scribing, and more.

Operations: A global presence with a focus on U.S. healthcare markets.

Clientele: Trusted by top healthcare organisations such as The GI Alliance Management.

IKS Health leverages technology to reduce inefficiencies in healthcare and improve patient outcomes.

What is the objective of the IPO?

The primary objectives of the Inventurus Knowledge Solutions IPO are:

To facilitate an Offer for Sale (OFS) of up to 18,795,510 equity shares with a face value of ₹1 each by the selling shareholders.

To achieve the benefits of listing the equity shares on the stock exchanges, enhancing visibility and providing liquidity for the shareholders.

How much is reserved for retail and other investors?

The IPO allocation is as follows:

Qualified Institutional Buyers (QIBs): Up to 75%

Non-Institutional Investors (NIIs): At least 15%

Retail Investors: At least 10%

What are the key strengths and risks?

Strengths:

A comprehensive, one-stop platform serving outpatient and inpatient care needs.

Strong brand presence among U.S.-based healthcare providers.

Sustainable and scalable business model with cost-saving advantages.

Revenue from the top 10 clients consistently growing, ensuring stability.

Demonstrated strong financial performance with a revenue growth of CAGR 54.29% (FY22-FY24).

Risks:

Heavy reliance on the U.S. healthcare market exposes the company to economic and regulatory risks.

Rapid advancements in AI/ML may challenge the competitiveness of current solutions.

Complex integration with diverse electronic health record (EHR) systems.

Potential cyberattack risks due to handling sensitive patient data.

What is the financial performance of Inventurus Knowledge Solutions?

The company has shown remarkable growth over the years:

Period Ended	30 Sep 2024	31 Mar 2024	31 Mar 2023	31 Mar 2022
Assets	₹2,790.5 Cr	₹3,027.5 Cr	₹988.3 Cr	₹787.5 Cr
Revenue	₹1,282.9 Cr	₹1,817.9 Cr	₹1,031.3 Cr	₹763.6 Cr
Profit After Tax	₹208.6 Cr	₹370.5 Cr	₹305.2 Cr	₹233.0 Cr

What is the allotment and listing timeline?

Basis of allotment: December 17, 2024

Refund initiation: December 18, 2024

Shares credited to demat accounts: December 18, 2024

Listing date: December 19, 2024

Should you invest in the Inventurus Knowledge Solutions Limited IPO?

Inventurus Knowledge Solutions Limited offers a promising investment opportunity with its strong brand, scalable business model, and robust financial growth. However, investors must consider the risks, such as dependence on the U.S. market and rapid technological changes in healthcare.

Evaluate your risk appetite and investment goals carefully before participating in this IPO.

Post Views: 357